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BLNK: a Central Linker Protein in B Cell Activation
regulation of signaling pathways to generate secondChong Fu,1,2 Christoph W. Turck,5
messengers upon BCR activation.Tomohiro Kurosaki,6 and Andrew C. Chan1,3,4,7
Multiple downstream signaling pathways activated1Center for Immunology
through the BCR are required for normal B cell function2Program in Molecular Genetics
(reviewed in DeFranco, 1997). Tyrosine phosphorylation3Division of Rheumatology
of PLCg1 and g2 hydrolyzes PIP2 to IP3 and diacyl-Departments of Medicine and Pathology
glycerol, which results in increases in free cytoplasmic4Howard Hughes Medical Institute
calcium ([Ca21]i) and activation of protein kinase C,Washington University School of Medicine
respectively. Increases in [Ca21]i regulate multiple cal-St. Louis, Missouri 63110
cium-dependent enzymes, including the serine/threo-5Howard Hughes Medical Institute
nine phosphatase calcineurin, to dephosphorylate NF-University of California
AT, which results in its translocation from the cytoplasmSan Francisco, California 94121
to the nucleus (reviewed inRao et al., 1997). Involvement6Kansai Medical School
of small G proteins, including both Ras and Rho familyInstitute of Hepatic Research
GTPases, also play critical roles in B cell activation. RasDepartment of Molecular Genetics
activation is mediated through the translocation of theMoriguchi 570
Son of Sevenless (SoS) exchange factor to membraneJapan
bound Ras, which results in activation of the mitogen-
activated protein (MAP) kinase pathway (reviewed in
Schlessinger, 1994). Membrane localization of SoS is
Summary mediated through the translocation of adapter protein
complexes. In addition to Ras, recent studies also
Linker or adapter proteins provide mechanisms by demonstrate the importance of Rho-GTPases. Tyrosine
which receptors can amplify and regulate downstream phosphorylation of the Vav guanine nucleotide ex-
effector proteins. We describe here the identification change factor, which results in up-regulation of its ex-
of a novel B cell linker protein, termed BLNK, that change factor activity, has been proposed to regulate
interfaces the B cell receptor±associated Syk tyrosine the subsequent activation of JNK and the p38 MAPK
kinase with PLCg, the Vav guanine nucleotide ex- pathways (Bustelo and Barbacid, 1992; Crespo et al.,
change factor, and the Grb2 and Nck adapter proteins. 1996; Crespo et al., 1997; Teramoto et al., 1997). While
Tyrosine phosphorylation of BLNK by Syk provides these downstream signaling pathways are mediated
docking sites for these SH2-containing effector mole- through distinct signaling effector proteins, the coordi-
cules that, in turn, permits the phosphorylation and/ nate activation of these pathways is required for normal
or activation of their respective signaling pathways. B cell function (Healy et al., 1997). Absence of NF-kB
Hence, BLNK represents a central linker protein that and JNK activation in the presence of normal MAPK and
bridges the B cell receptor±associated kinases with a NF-AT signaling is associated with B cell tolerance.
multitude of signaling pathways and may regulate the While much has been learned as to how calcium, Ras,
biologic outcomes of B cell function and development. and Rho-GTPases may regulate their downstream tar-
gets, the mechanisms by which the BCR-associated
PTKs regulate PLCg, Grb2, and Vav remain unclear.Introduction
While Syk can phosphorylate PLCg in vitro (Law et al.,
1996), expression of a functional BCR, Fyn, and Syk inLymphocyte activation initiates a program of biochemi-
nonlymphoid cells does not induce PLCg phosphoryla-cal events involving a variety of distinct signaling path-
tion or increased [Ca21]i (Richards et al., 1996). Theseways that culminate in gene transcription, clonal expan-
reconstitution studies suggest the existence of hemato-sion, and cellular differentiation (reviewed in DeFranco,
poietic cell±specific proteins that may link Sykwith PLCg1997; Kurosaki and Kurosaki, 1997; Reth and Wienands,
activation. We have previously identified two tyrosine1997). The B cell antigen receptor utilizes receptor-
phosphoproteins, pp70 and pp68, that associate withencoded signaling motifs termed ITAMs (for immunore-
Grb2, Vav, and PLCg following BCR activation and thatceptor tyrosine-based activation motifs) to activate non-
may represent potential linker proteins to interface thereceptor tyrosine kinases. Sequential activation of at
BCR-associated PTKs with downstream effector signal-least three families of kinasesÐthe Src-family of PTKs
ing molecules (Fu and Chan, 1997). Here we describe(including Fyn, Lyn, and Blk), Syk, and BtkÐare required
the molecular and functional characterization of thesefor phosphorylation of multiple cellular proteins to regu-
two proteins, which we have termed BLNK for B-celllate downstream signaling pathways. Deficiencies in any
linker proteins.of these three families of PTKs result in defective or
aberrant B cell function and development. Hence, these
ResultsB cell receptor (BCR)-associated PTKs are requisite for
Molecular Characterization of pp70 and pp68
Our previous studies had identified two common tyro-7 To whom correspondence should be addressed (e-mail: chan@im.
wustl.edu). sine phosphoproteins, pp70 and pp68, that interact with
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Figure 1. Characterization of BLNK
(A) Biochemical and molecular characterization of BLNK. Top, Commassie blue staining of the purified proteins is shown on the left. The
deduced amino acid sequence of human (top) and murine (bottom) BLNK is shown on the right. The seven peptide sequences obtained from
protein sequencing are underlined. The 23 amino acids not present in the alternatively spliced form of human BLNK-s (amino acids 203±225)
are denoted by the boxed sequence. Bottom, schematic diagrams of hBLNK, hBLNK-s, and hSLP-76. The 470 bp PCR probe is depicted at
the top. The percentage of amino acid identity of the various domains between BLNK and SLP-76 is shown.
(B) BLNK mRNA is predominantly expressed in the spleen. Human multi-tissue Northern blots (Clontech) were hybridized with BLNK (top) or
b-actin (bottom) cDNA probes.
(C) BLNK proteins are expressed only in B cell lines. Total cell lysates from different cell lines were immunoblotted with an anti-BLNK antiserum
(top) or an anti-b-actin MAb (bottom). Ramos, Daudi, and Raji are human Burkitt lymphoma cells; WEHI-231, A20, and 70Z/3 are mouse B
cells; Jurkat and EL4 are transformed T cell lines; K562 is a human erythroleukemia line; Thp-1 is a human monocytic cell line; RBL-1 is a rat
basophil leukemia cell line; 293 is a human embryonic kidney line; and LAK represents lymphokine-activated killer cells.
Grb2, PLCg, and Vav following BCR activation (Fu and B cells, we have termed pp70 as BLNK for B-cell linker
protein.Chan, 1997). These two phosphoproteins were purified
from 5 3 1010 BCR-activatedhuman Ramos B cells using Since the seven peptides derived from both pp70 and
pp68 were all present in the open reading frame, wea two-step affinity purification protocol based on their
ability to bind the C-terminal SH2 domain of PLCg1 reasoned that pp68 may arise from alternative splicing of
the BLNK gene transcript. Analysis of RT±PCR productsand an anti-phosphotyrosine (PTyr) MAb. Seven internal
peptides, obtained from microsequencing of pp70 and from human B cell mRNA demonstrated the existence
of a shorter form of BLNK that lackedbase pairs 760±828pp68, were obtained, and the sequences KKPTTPLK
and KRVYNIPVRFIEATK were used to generate degen- of the human BLNK (hBLNK) cDNA. Expression of this
shortened form of the hBLNK cDNA (designated aserate oligonucleotides (sense, TCGAGAATTCAAA/AAA/
GCCIACA/ G/T/CACA/G/T/CCC; antisense, TCGAGGAT hBLNK-s) gave rise to a protein that comigrated with
pp68 (data not shown). Hence, pp70 and pp68 representCCACIGGA/G/TATA/GTTA/GTAA/G/T/CAC). A 470 bp
PCR product was obtained and used to isolate a 1.6 kb alternatively spliced forms of the hBLNK gene.
A mouse cDNA clone was isolated from a lact mousecDNA fragment from a lyes library constructed from EBV-
transformed human B cells (Figure 1A). It contained an pre-B cell library using the human cDNA as a probe.
This clone encoded a 457±amino acid polypeptide andopen reading frame that encodes a 456 amino acid poly-
peptide. The presence of a stop codon upstream of shares 82% identity to the predicted human BLNK se-
quence (Figure 1A). In contrast to hBLNK, alternativethe first ATG and the presence of a Kozak sequence
indicated that this represented a full-length cDNA. Ex- splicing of the mBLNK gene transcript was not detected
(data not shown). BLNK demonstrated its greatest ho-pression of this cDNA in HeLa cells resulted in a protein
that comigrated with pp70 (data not shown). Since pp70 mology with the SLP-76 linker protein, though the de-
gree of homology was only z33% (Jackman et al., 1995).interacts with a variety of signaling effector proteins in
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Analysis of BLNK mRNA expression demonstrated its BLNK interacts with PLCg, Vav, Grb2, and Nck
highest levels of expression in the spleen, with lower Since pp70 and pp68 interact with PLCg, Vav, and Grb2
levels of expression in the liver, kidney, pancreas, small (Fu and Chan, 1997), and since we have recently demon-
intestines, and colon (Figure 1B). Analysis of BLNK pro- strated that SLP-76 interacts with Nck following TCR
tein expression in hematopoietic and fibroblast cell lines activation (J. B. W. and A. C. C., unpublished data), we
from human, mouse, or rat origin demonstrated their addressed the possibility that BLNK may serve as a
preferential expression in human and mouse B cells linker protein to bridge Syk with downstream effector
(Figure 1C). While all human B cells examined expressed signaling molecules. Immunoprecipitates of an epitope-
both BLNK and BLNK-s, mouse B cells expressed only tagged form of BLNK were examined for association
one detectable form of the BLNK protein. Protein ex- with PLCg1, Vav, Grb2, or Nck from resting or BCR-
pression was not detected in a variety of T cell lines activated Daudi cells (Figure 3A, lanes 1±8). Conversely,
or other hematopoietic- and nonhematopoietic-derived PLCg1, Vav, Grb2, or Nck were immunoprecipitated and
cell lines (Figure 1C; data not shown). Hence, BLNK analyzed for their ability to interact with Myc-BLNK (Fig-
protein expression among hematopoietic cells appears ure 3A, lanes 9±16). The association of BLNK with
limited to the B cell lineage, with human B cells express- PLCg1, Vav, or Nck was readily detected following BCR
ing two alternatively spliced forms and mouse B cells activation, though a low level of association of BLNK
expressing a single form. was detected with PLCg1, Vav, and Nck in resting cells
with substantially longer exposures of the film (data not
Tyrosine Phosphorylation of BLNK by Syk shown). These data are consistent with our in vitro map-
The generation of anti-BLNK antibodies permitted us to ping studies demonstrating the requirements for the
analyze the phosphorylation status of BLNK and BLNK-s SH2 domains of PLCg1, Vav, and Nck in this interaction
in resting and activated cells. Immunoprecipitation of (Fu and Chan, 1997; data not shown). In contrast, associ-
BLNK and BLNK-s from resting and BCR-activated hu- ation of BLNK with Grb2 was readily observed in resting
man Daudi B cells demonstrated that BLNK and BLNK-s cells (Figure 3A, top panels, lanes 5 and 13) and was
undergo receptor-dependent tyrosine phosphorylation augmented following BCR activation (Figure 3A, top
that peaks at 2 min following BCR activation and returns
panels, lanes 6 and 14). These studies were similarly
to near basal levels by 30 min (Figure 2A, lanes 1±7).
consistent with our in vitro mapping studiesdemonstrat-
No differences in the kinetics of phosphorylation or
ing the involvement of both SH3 and SH2 domains within
dephosphorylation were detected between BLNK and
Grb2 in its interaction with tyrosine phosphorylatedBLNK-s. Similarly, mBLNK was phosphorylated in a re-
BLNK and BLNK-s (Fu and Chan, 1997).
ceptor-dependent fashion peaking at 10 min following
To ensure that these interactions were not the resultBCR cross-linking, though tyrosine phosphorylation was
of overexpression, we also analyzed the ability of en-maintained even up to 60 min following BCR activation
dogenous BLNK and BLNK-s to interact with PLCg1,(Figure 2A, lanes 8±15).
Vav, Grb2, and Nck in resting and activated Daudi BTo identify the PTKs responsible for BLNK phosphory-
cells (Figure 3B). Similar to Myc-BLNK, both BLNK andlation, we analyzed BLNK phosphorylation when ex-
BLNK-s associated with PLCg1, Vav, and Nck in a recep-pressed in a cohort of chicken B cell lines lacking Lyn,
tor-dependent fashion. In addition, BLNK and BLNK-sSyk, or Btk (Figure 2B) (Takata and Kurosaki, 1996; Ta-
associated with Grb2 in resting cells, and its stoichiome-kata et al., 1994). While expression of hBLNK in parental
try of association was increased following BCR cross-DT40 cells demonstrated its tyrosine phosphorylation
linking (Figure 3B, lanes 5±6). Hence, the associationfollowing BCR cross-linking (lanes 1±2), tyrosine phos-
of BLNK with these four effector proteins in B cellsphorylationof hBLNKwas attenuated inLyn2 cells (lanes
supported the notion that BLNK may serve as a central3±4) and was abrogated in Syk2 cells (lanes 5±6). In
protein to link the BCR-associated PTKs with down-contrast, BLNK was phosphorylated to a similar level in
stream signaling functions.Btk2 cells (lanes 7±8). The attenuation of BLNK phos-
phorylation in Lyn2 cells suggested that either Lyn con-
tributed to BLNK phosphorylation or merely reflected
Interaction of Grb2 with BLNKthe upstream requirement of Lyn in Syk activation,
Since BLNK associated with Grb2, which, in turn, inter-which, in turn, is responsible for BLNK phosphorylation
acts with the SoS guanine nucleotide exchange factor,(Chan et al., 1994; Kurosaki et al., 1994; El-Hillal et al.,
we analyzed the assembly of potential BLNK/Grb2/SoS1997).
complexes. Consistent with the basal association ofTo distinguish between these possibilities, we ana-
BLNK with Grb2, SoS also coimmunoprecipitated withlyzed the ability of BLNK to be phosphorylated by each
Myc-BLNK in resting cells (Figure 4A, top and middlePTK in insect cells. While coexpression of Syk and BLNK
panels, lane 1), an interactionthat is likely tobe mediatedresulted in BLNK phosphorylation (Figure 2C, top panel,
through Grb2. As the stoichiometry of association be-lane 2), coexpression of BLNK with either Lyn or Btk
tween Grb2 and BLNK increased following BCR cross-did not phosphorylate BLNK (lanes 3±4) despite higher
linking (middle panel), the association of SoS in BLNKlevels of expression of Lyn and Btk compared to Syk
immunoprecipitates also increased with BCR activation(Figure 2C, bottom panel). Coexpression of Lyn with Btk,
(top panel, lanes 1±2). Hence, the assembly of a BLNK/which also results in Btk activation, failed to result in
Grb2/SoS complex provides a mechanism by whichsignificant BLNK phosphorylation (data not shown). To-
BLNK may regulate the Ras signaling pathway.gether, these studies indicate that Syk is responsible
for BLNK phosphorylation. Since translocation of the Grb2/SoS complex to the
Immunity
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Figure 2. Tyrosine Phosphorylation of BLNK by Syk
(A) Kinetics of BLNK tyrosine phosphorylation in Daudi cells and mouse B cells. Daudi cells (lanes 1±7) or mouse splenocytes (lanes 8±15)
were stimulated for the indicated times with an anti-human IgM F(ab)92 fragment or an anti-mouse IgM F(ab)92 fragment, respectively. BLNK
was then immunoprecipitated and analyzed by immunoblotting with the indicated antibodies.
(B) BLNK tyrosine phosphorylation is affected in Lyn2 and in Syk2 DT40 cells. Myc-hBLNK was transfected into DT40 cells (lanes 1±2) or its
derivative Lyn2 (lanes 3±4), Syk2 (lanes 5±6), or Btk2 (lanes 7±8) cells. Following transfection, the cells were either left unstimulated (lanes 1,
3, 5, and 7) or stimulated with an anti-chicken IgM MAb (M4; lanes 2, 4, 6, and 8). Myc-hBLNK was immunoprecipitated and immunoblotted
with the indicated antibodies.
(C) Syk phosphorylates BLNK in insect cells. Myc-hBLNK was expressed in Sf9 cells either alone (lane 1) or coexpressed with GST-Syk (lane
2), GST-Lyn (lane 3), or GST-Btk (lane 4). BLNK was immunoprecipitated and analyzed by immunoblotting with the indicated antibodies.
Expression levels of the kinases were confirmed by immunoblotting with an anti-GST MAb (bottom panel).
membrane is important in its codistribution with mem- top panel, lanes 1±2). Conversely, while Grb2 associates
with BLNK (Figure 4C, bottom panel, lanes 3±4), Shcbrane-localized Ras (reviewed in Schlessinger, 1994),
we analyzed the cellular localization of BLNK in resting was not detected in BLNK immunoprecipitates (Figure
4C, middle panel, lanes 3±4). Hence, BLNK/Grb2 com-and activated cells. BCR activation resulted in the trans-
location of both BLNK and Grb2 to the membrane frac- plexes may represent a Shc-independent mechanism in
regulating the Grb2/SoS signaling pathway.tion (Figure 4B, top two panels, lanes 4±5). Treatment of
cells with pervanadate, a tyrosine phosphatase inhibitor
that mimics receptor activation (Secrist et al., 1993), Regulation of PLCg Function by BLNK
To investigate the molecular mechanisms by which ty-resulted in a further increase in the translocation of both
BLNK and Grb2 in the membrane fraction (Figure 4B, rosine phosphorylation of BLNK may regulate B cell
activation, we generated stable B cell clones that over-top two panels, lane 6). Hence, BCR activation results
in the colocalization of BLNK/Grb2/SoS complexes to express a Myc epitope±tagged version of wild-type
BLNK [designated as BLNK(WT)] or express a Myc epi-the membrane fraction.
As the Shc adapter protein, which can associate with tope±tagged mutant version of BLNK [designated as
BLNK(4F)] in which Tyr-72, -84, -96, and -178 were mu-the BCR complex and Syk, interacts with Grb2 following
BCR activation and regulates Ras activation (Harwood tated to Phe. These four tyrosine residues were chosen
because they have a similar motif to the three homolo-and Cambier, 1993; Saxton et al., 1994; Smit et al., 1994;
Nagai et al., 1995; D'Ambrosio et al., 1996; Harmer and gous tyrosine residues that are phosphorylated on SLP-
76 (Bubeck-Wardenburg et al., 1996; Fang et al., 1996;DeFranco, 1997), we examined whether the BLNK/Grb2/
SoS complex could coimmunoprecipitate with Shc. Shc Raab et al., 1997). All clones examined expressed com-
parable levels of surface BCR (data not shown). Bothwas immunoprecipitated from resting or activated B
cells and analyzed by immunoblotting with anti-BLNK, epitope-tagged versions of BLNK were expressed at
3- to 5-fold over endogenous BLNK (Figure 5A, bottomanti-Shc, or anti-Grb2 antibodies (Figure 4C, lanes 1±2).
While Shc associates with Grb2 only following BCR panel). Similar to endogenous BLNK, Myc-BLNK(WT)
was phosphorylated following BCR activation (Figurecross-linking (Figure 4C, bottom panel, lanes 1±2), BLNK
was not detected in Shc immunoprecipitates (Figure 4C, 5A, top panel, lanes 1±4). In contrast, phosphorylation
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Figure 3. BLNK Associates with PLCg, Vav, Grb2, and Nck
(A) Interaction of Myc-BLNK with PLCg, Vav, Grb2, and Nck. Myc-BLNK(WT) was expressed in Daudi cells and immunoprecipitated from
lysates of resting (2) or BCR-activated cells (1). Anti-Myc immunoprecipitates were analyzed by immunoblotting with the indicated antibodies.
The bottom panel demonstrates comparable levels of Myc-BLNK(WT) in all immunoprecipitates. Conversely, immunoprecipitates with anti-
PLCg1 (lanes 9±10), anti-Vav (lanes 11±12), anti-Grb2 (lanes 13±14), or anti-Nck (lanes 15±16) antiserum were immunoblotted with an anti-
Myc MAb (top panel). The bottom panel demonstrates comparable levels of PLCg1, Vav, Grb2, or Nck in each immunoprecipitate. IgL, light
chain of the immunoprecipitating Ab.
(B) Interactions of BLNK and BLNK-s with PLCg, Vav, Grb2, and Nck. PLCg1 (lanes 1±2), Vav (lanes 3±4), Grb2 (lanes 5±6), or Nck (lanes 7±8)
were immunoprecipitated from resting (2) or BCR-activated Daudi cells (1) and immunoblotted with an anti-BLNK MAb (top panel). The
bottom panel demonstrates comparable levels of PLCg1, Vav, Grb2, and Nck present in resting or BCR-activated conditions.
of Myc-BLNK(4F) was significantly reduced when com- alterations in the ability of the BCR to regulate [Ca21]i.
Overexpression of BLNK(WT) in two representative clonespared to wild-type BLNK (Figure 5A, lanes 2 and 6). In
addition, tyrosine phosphorylation of endogenous BLNK (WT1 and WT16) resulted in an z50% increase in [Ca21]i
as compared to control cells (Figure 6A, left column).was reduced in cells expressing BLNK(4F).
To determine the functional role of BLNK, we as- Conversely, expression of BLNK(4F) in representative
clones (4F31 and 4F49) resulted in a 50%±67% decreasesessed the tyrosine phosphorylation of PLCg in cells
that overexpressed BLNK(WT) or expressed BLNK(4F). in BCR-mediated [Ca21]i as compared to control cells
(Figure 6A, right column). Addition of EGTA retained theTyrosine phosphorylation of both PLCg1 and PLCg2 was
augmented in cells overexpressing BLNK(WT) as com- differences observed in [Ca21]i in cells overexpress-
ing BLNK(WT) or cells expressing BLNK(4F) (data notpared to parental cells (Figure 5B, top panel, lanes 1±4).
Conversely, tyrosine phosphorylation of PLCg1/g2 was shown). Hence, the observed differences in [Ca21]i fol-
lowing BCR stimulation are derived, in part, throughdecreased in cells expressing BLNK(4F) (Figure 5B,
lanes 3±6). In addition, while both endogenous and Myc- intracellular stores and likely reflect differences in the
enzymatic activation of PLCg1 and PLCg2.BLNK(WT) associated with PLCg1/g2 following BCR ac-
tivation, the association of Myc-BLNK(4F) with PLCg1/ To further investigate the mechanism(s) by which
BLNK may regulate tyrosine phosphorylation of PLCg1,g2 was diminished (Figure 5B, middle panel, lanes 1±6).
To ensure that the effect on PLCg1/g2 phosphorylation we tested whetherBLNK could directly facilitate tyrosine
phosphorylation of PLCg1 by Syk. Tyrosine phosphory-was specific to BLNK-regulated proteins and did not
reflect a mere global decrease in the phosphorylation lation of PLCg1 by Syk was analyzed in insect cells in
the absence or presence of BLNK. While coexpressionof cellular proteins, we examined the tyrosine phosphor-
ylation of Shc. In contrast to the effects on PLCg1/g2 of PLCg1 and Syk resulted in a low level of PLCg1 phos-
phorylation (Figure 5C, top panel, lane 2), the coexpres-phosphorylation, tyrosine phosphorylation of Shc was
not affected by BLNK (Figure 5B, lanes 7±12). sion of PLCg1, BLNK, and Syk augmented PLCg1 phos-
phorylation (Figure 5C, lane 3). Together, these studiesThe changes in PLCg1/g2phosphorylation, which me-
diate their enzymatic activities, were also reflected in suggest that tyrosine phosphorylation of BLNK provides
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Figure 4. Interaction of BLNK and Grb2
(A) Coimmunoprecipitation of BLNK, Grb2, and SoS. Anti-Myc immunoprecipitates of Daudi cells overexpressing Myc-BLNK(WT) from lysates
of resting (lane 1) or BCR-activated cells (lane 2) were immunoblotted with the indicated antibodies. IgL, light chain of the immunoprecipi-
tating Ab.
(B) BLNK is translocated into the membrane fraction following BCR stimulation. Cytosolic and membrane fractions were prepared from
resting (2), BCR stimulated (1), or pervanadate stimulated (PV) cells as described in Experimental Procedures. Top panel, BLNK was
immunoprecipitated from cytosolic (lanes 1±3) or membrane (lanes 4±6) fractions and analyzed by immunoblotting. Four times as many cells
were used in the membrane fractions. Bottom three panels, cytosolic and membrane fractions were immunoblotted with the indicated
antibodies. Equal numbers of cells were used in each fraction. Analysis of the nonmembrane localized c-Jun kinase 1 (JNK1) and the
transmembrane protein CD45 (bottom two panels) confirmed the integrity of the cytosol and membrane fractions, respectively.
(C) BLNK/Grb2 complexes are independent of Shc/Grb2 complexes. Shc (lanes 1±2), BLNK (lanes 3±4), or Grb2 (lanes 5±6) were immunoprecipi-
tated from resting (2) or BCR-activated Daudi B cells (1) and immunoblotted for BLNK (top), Shc (middle), and Grb2 (bottom).
a scaffolding to recruit and bind PLCg1 and, in turn, resulted in up to 70% inhibition of NF-AT activity. The
mean level of expression of Myc-BLNK(4F) in these ex-facilitate the tyrosine phosphorylation of PLCg1 by the
Syk PTK. periments ranged up to z2.5-fold as compared to en-
dogenous BLNK (Figure 6C, right panel). Hence, theAs transcriptional activation of the nuclear factor of
activated T cells (NF-AT) plays an important role in BCR- requirement for tyrosine phosphorylation of BLNK by
Syk in regulating PLCg1 tyrosine phosphorylation, in-mediated proliferation (Ranger et al., 1998; Yoshida et
al., 1998), we measured the ability of BLNK to regulate creases in [Ca21]i, and NF-AT transcriptional activity
suggests that BLNK likely plays an important role inthe transcriptional activation of NF-AT-responsive ele-
ments. In these experiments, mouse A20 B cells were regulating PLC-mediated signaling pathways activated
by the BCR.used, since they exhibited substantially higher transfec-
tion efficiencies than Daudi B cells (data not shown).
Transient overexpression of Myc-BLNK(WT) resulted in Discussion
up to a 2.7-fold increase in NF-AT transcriptional activity
as compared to vector control transfected cells (Figure The current paradigm for growth factor receptor signal-
ing involves receptor dimerization, activation of the re-6B). The mean level of overexpressionof Myc-BLNK(WT)
achieved in these cells was substantially less than the ceptor-encoded tyrosine kinases, phosphorylation of ty-
rosine residues within their cytoplasmic domains, andendogenous BLNK (Figure 6B, right panel). Transfection
of up to 60 mg of myc-BLNK(WT) cDNA, which resulted recruitment of effector proteins such as PLC, Shc, Grb2,
RhoGAP, and PI3K to the activated receptor (reviewedin an z3-fold overexpression of Myc-BLNK(WT) as com-
pared to endogenous BLNK, did not result in any addi- in Ullrich and Schlessinger, 1990; Schlessinger, 1997).
In contrast to growth factor receptors, antigen receptorstional increase in NF-AT transcriptional activity (data not
shown). Conversely, expression of BLNK(4F) resulted in activate a cascade of cytoplasmic PTKs to regulate
these downstream effector functions (reviewed in Chana dose-dependent decrease in NF-AT activity as com-
pared to vector control transfected cells (Figure 6C). et al., 1994; DeFranco, 1997; Reth and Wienands, 1997).
Our studies here define an additional level of regulationTransfection of increasing amounts of myc-BLNK(4F)
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Figure 5. BLNK Regulates PLCg Tyrosine Phosphorylation
(A) Tyrosine phosphorylation of stably transfected BLNK proteins. Myc-BLNK(WT) or Myc-BLNK(4F) was stably expressed in Daudi cells.
BLNK proteins were immunoprecipitated and analyzed by immunoblotting with an anti-PTyr MAb (top panel) or an anti-BLNK MAb (bottom
panel). WT, Myc-BLNK(WT); C, vector control; 4F, Myc-BLNK(4F). The data shown here are representative of at least two clones of each
transfected cDNA.
(B) Regulation of PLCg1/g2 tyrosine phosphorylation by BLNK. PLCg1/g2 (lanes 1±6) were immunoprecipitated from either resting (2) or BCR-
stimulated (1) Daudi clones that overexpress BLNK(WT) (lanes 1±2), vector control (lanes 3±4), or BLNK(4F) (lanes 5±6), and immunoblotted
with the indicated antibodies. The antiserum used for immunoprecipitation recognizes both PLCg1 and PLCg2. Lanes 7±12 represent Shc
immunoprecipitates from either resting (2) or BCR-stimulated (1) Daudi clones that overexpress wild-type BLNK (lanes 7±8), vector control
(lanes 9±10), or BLNK(4F) (lanes 11±12) immunoblotted with the indicated antibodies. Similar data were observed from a minimum of two
independent clones for each cDNA.
(C) BLNK facilitates PLCg1 tyrosine phosphorylation by Syk. FLAG-tagged PLCg1 was coexpressed in insect Sf9 cells with Myc-BLNK (lane
1), coexpressed with GST-Syk (lane 2), or coexpressed with GST-Syk and Myc-BLNK (lane 3). Forty hours following infection, FLAG-PLCg1
was immunoprecipitated and immunoblotted with an anti-PTyr MAb (PY20, top panel). Expression levels of FLAG-PLCg1, GST-Syk, and Myc-
BLNK were confirmed by immunoblotting analysis as demonstrated in the bottom three panels.
mediated by linker proteins that permits the BCR-acti- SoS guanine nucleotide exchange factor as well as the
translocation of BLNK from the cytoplasmic to mem-vated PTKs to activate downstream effector proteins.
We report here the identification and characterization brane fraction provides a mechanism by which BLNK/
Grb2/SoS complexes may regulate the Ras pathway.of a novel PTK substrate, BLNK, which is phosphory-
lated by Syk. Overexpression of wild-type BLNK results However, we were unable to detect anysignificant differ-
ences in the activation of Erk1 and Erk2 in cells overex-in enhanced tyrosine phosphorylation of PLCg, recep-
tor-mediated calcium responses and transcriptional ac- pressing BLNK(WT) or BLNK(4F) (data not shown). Our
inability to detect significant differences in activationtivation of NF-AT. Conversely, expression of a dominant
negative mutant of BLNK results in decreased PLCg ty- of the MAPK pathway may reflect the redundancy of
signaling pathways leading to Ras activation. In B cells,rosine phosphorylation, calcium, and NF-AT responses.
That BLNK is phosphorylated by Syk and enhances the Shc adapter protein has been proposed to link the
BCR with Ras activation (Saxton et al., 1994; Smit et al.,PLCg phosphorylation by Syk indicates two distinct
functions for BLNK in B cell activation. First, tyrosine 1994; D'Ambrosio et al., 1996; Harmer and DeFranco,
1997). Analysis of Shc mutants that cannot bind Grb2phosphorylation of BLNK recruits PLCg to BLNK. Sec-
ond, the colocalization of BLNK with Syk (C. F. and do not exhibit any effects on Erk1 or Erk2 activation
(Harmer and DeFranco, 1997) and may reflect the abilityA. C. C., unpublished data), in turn, facilitates the tyro-
sine phosphorylation and subsequent activation of the of BLNK to regulate Grb2/SoS independent of Shc/Grb2
complexes. Similar degrees of redundancy have beenassociated PLCg. These results suggest that BLNK likely
bridges the BCR-associated PTKs with PLCg-mediated demonstrated for Ras activation by the BCR-ABL onco-
gene and the epidermal growth factor (EGF) receptorsignaling pathways.
The association of BLNK with Grb2 and, in turn, the (Gotoh et al., 1994; Goga et al., 1995). Mutation of the
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Figure 6. Regulation of PLCg-Mediated Re-
sponses by BLNK
(A) Regulation of [Ca21]i by BLNK. [Ca21]i was
measured by spectrofluorimetry following
stimulation with an anti-hIgM F(ab)92 Ab (3
mg/ml). The left column depicts two represen-
tative clones overexpressing BLNK(WT) or
parental control cells. The right column de-
picts two representative clones expressing
BLNK(4F) or parental control cells. This data
is representative of greater than ten indepen-
dent experiments of multiple clones.
(B) Increased NF-AT transcriptional activity
by BLNK(WT). A control plasmid vector or a
vector encoding Myc-BLNK(WT) at the indi-
cated concentrations was transiently cotrans-
fected into 107 A20 cells with a NF-AT reporter
plasmid as described in Experimental Proce-
dures. Induction of NF-AT activity was ana-
lyzed in resting cells, cells stimulated with an
anti-mouse IgG F(ab)92 fragment (4.0 mg/ml),
or cells stimulated with 0.5 mg/ml PDBu and
0.5 mM ionomycin for 6 hr. Data are graphed
as percentage of luciferase activity compared
to cells stimulatedwith PDBu plus ionomycin.
Cells (2 3 105) were lysed and analyzed for
Myc-BLNK overexpression, as compared to
endogenous BLNK in the right panel. Data
are representative of greater than five inde-
pendent experiments.
(C) Attenuation of NF-AT transcriptional activ-
ity by BLNK(4F). A control plasmid vector or
the indicated concentrations of a vector en-
coding Myc-BLNK(4F) was transiently co-
transfected into A20 cells with a NF-AT re-
porter plasmid as described in Figure 6B. The
level of expression of Myc-BLNK(4F) as com-
pared to endogenous BLNK was determined
by immunoblotting with an anti-BLNK antise-
rum (right panel). Data are representative of
greater than five independent experiments.
Grb2-binding sites within BCR-ABL retained the ability Grb2 interaction likely contributes to one of these path-
ways in B cell function.of theBCR-ABL mutant to transform hematopoieticcells
through a Shc/Grb2-mediated pathway (Goga et al., The BLNK polypeptide demonstrates its highest ho-
mology (z33% amino acid identity) to the SLP-76 linker1995). In addition, an EGFR that is unable to bind Grb2
can still induce Shc phosphorylation and Ras activation protein that we and others have demonstrated to be an
in vivo substrate for ZAP-70 and Syk (Jackman et al.,(Gotoh et al., 1994). Hence, multiple signaling mecha-
nisms likely contribute to Ras activation, and the BLNK/ 1995; Bubeck-Wardenburg et al., 1996; Raab et al.,
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(Zhang et al., 1998). While T cells appear to utilize two
linker proteins (SLP-76 and LAT), both of which are sub-
strates of ZAP-70, B cells appear to utilize a single linker
proteinÐBLNK. Neither SLP-76 nor LAT are expressed
in B cells (Fu and Chan, 1997; Zhang et al., 1998). In
addition, we do not detect the binding of any tyrosine
phosphoproteins in the 30±45 K Mr range to PLC, Grb2,
or Vav (data not shown). Moreover, while SLP-76 and
LAT interacts in vivo with Nck, Vav, Grb2, and PLC (Jack-
man et al., 1995; Onodera et al., 1996; Tuosto et al.,
1996; Wu et al., 1996; Zhang et al., 1998; J. B. W. and
A. C. C., unpublished data), BLNK interacts in vivo with
Figure 7. BLNK, a Central Linker Protein in BCR Activation all four effector proteins. Together, these data indicate
Studies in T cells suggest that the TCR-associated PTKs ZAP-70 that BLNK likely serves as the central linker protein to
and Syk phosphorylate two linker proteins, SLP-76 and LAT. Neither link the BCR-activated PTKs with these effector func-
SLP-76 nor LAT are expressed in B cells. Our data here demonstrate
tions.that BLNK associates with Vav, Grb2, PLCg, and Nck, suggesting
The presence of multiple tyrosine residues withinthat B cells utilize a single linker protein in linking the Syk PTK with
BLNK further supports the idea that BLNK can serve asthese downstream effector proteins.
a scaffold for the spectrum of effector proteins. Each
tyrosine residue may demonstrate specificity for a spe-1997). Both BLNK and SLP-76 have similar structural
cific effector protein. Hence,specific binding sites withindomains with an N-terminal basic followed by an acidic
BLNK may dictate specificity of downstream signalingdomain, a proline enriched region within the middle third
pathways. In addition, the recruitment of distinct ef-of the molecule, and a C-terminal SH2 domain. While
fector molecules to BLNK may also permit different ef-SLP-76 has three YxxP sequences that are phosphory-
fectors to integrate their functions. Alternatively, but notlated by ZAP-70 and Syk (Bubeck-Wardenburg et al.,
exclusively, an effector protein may be able to bind at1996; Fang et al., 1996; Raab et al., 1997), BLNK contains
multiple tyrosine sites and provide amplification for the13 tyrosine residues, of which 6 are encompassed within
signaling cascade. For example, the insulin receptorYxxP sequences (Tyr-72, -84, -96, -178, -188, and -394).
substrate-1 (IRS-1) contains six YMXM motifs that canConsistent with the ability of BLNK to coimmunoprecipi-
bind the p85 subunit of PI3K and thereby amplify activa-tate with Vav, Nck, and PLCg1 in activated B cells, these
tion of the phosphoinositide pathway (Sun et al., 1991).tyrosine-containing consensus sequences have been
Analysis of each BLNK phosphorylation site is presentlyidentified to be favored SH2-binding sites for these ef-
underway to distinguish between these possibilities. Fi-fector proteins (Songyang et al., 1993, 1994). In addition,
nally, these linker proteins also contain SH2 domains,BLNK contains three PxxPxR/K sequences (residues 45,
which themselves may recruit additional downstream162, and 252) that have been identified as preferential
effector proteins such as FYB/SLAP-130, as in the casebinding sites for the Grb2 SH3 domains (Simon and
of SLP-76, to further modulate lymphocyte function (daSchreiber, 1995). Additional investigation is ongoing to
Silva et al., 1997; Musci et al., 1997a). Hence, the consor-identify the specific domains within BLNK that regulate
tium of effector proteins present within these macromo-its interactions with these effector proteins.
lecular complexes likely enables the integration of sig-While BLNK and SLP-76 share some structural and
naling components to coordinate downstream effectorfunctional similarities, BLNK also differs substantially
functions required for lymphocyte function.from SLP-76. Mutation of the three homologous tyrosine
residues within BLNK (Tyr-72, -84, and -96), which are
Experimental Proceduresphosphorylated within SLP-76, retained significant tyro-
sine phosphorylation (data not shown) and provides evi-
Cells and Antibodiesdence for a greater number of phosphorylation sites
Cell lines were maintained as recommended by the ATCC. A rabbit
within BLNK to interact with a greater number or variety anti-hBLNK antiserum (1791) was generated against a GST-fusion
of effector molecules. In addition, while SLP-76 directly protein encoding amino acids 324±456. A mouse anti-BLNK mono-
interacts in vivo with Vav and Nck (Onodera et al., 1996; clonal antibody (2C9 MAb) was generated against a GST-fusion
protein encoding amino acids 4±205 of hBLNK. Additional antibod-Tuosto et al., 1996; Wu et al., 1996; J. B. W. and A. C. C.,
ies used include anti-PTyr MAb (PY20, Transduction Labs), anti-Vavunpublished data), BLNK interacts in vivo directly with
antiserum and MAb (UBI), anti-PLCg1/2 antiserum (UBI), anti-PLCg2Vav, Nck, Grb2, and PLCg1. Moreover, while overex-
antiserum (Santa Cruz Biotechnology), anti-b-actin MAb (Sigma),pression of SLP-76 or expression of dominant negative
anti-GST MAb (SCB), anti-Myc MAb (9E10), anti-Grb2 antiserum and
mutants of SLP-76 has no effect on TCR-mediated cal- MAb (SCB and Transduction Labs), anti-SoS1 MAb (Transduction
cium mobilization (Musci et al., 1997b), overexpression Labs), anti-Nck antiserum and MAb (J. B. W. and A. C. C., unpub-
of BLNK(WT) or expression of BLNK(4F) affected the lished data, and Transduction Labs), anti-Shc antiserum and MAb
(UBI and SCB), anti-CD45 antiserum (McFarland et al., 1997), anti-ability of the BCR to activate the phosphoinositide path-
JNK1 antiserum (SCB), and anti-FLAG MAb (Kodak).way. Finally, while overexpression of SLP-76 has been
reported to result in hyperactivation of Erk1 (Musci et
Purification of pp70 and pp68al., 1997b), we were unable to detect any significant
Ramos cells (1.5 3 1010) were pelleted at 1000 RPM for 10 min and
differences in Erk1 activation in our analysis of B cells. resuspended at a concentration of 2 3 108/ml. Cells were activated
The in vivo interaction of the recently identified LAT with 24 mg/ml goat anti-hIgM F(ab)92 fragment (Jackson Labs) for 2
(pp36) with Grb2, PLC, and SLP-76 also raises additional min at 378C and lysed with an equal volume of lysis buffer (10 mM
Tris [pH 8.0], 1% NP-40, 150 mM NaCl) as previously described (Fuintriguing contrasts between T and B cells (Figure 7)
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and Chan, 1997). Cell lysates were pooled and clarified by centrifu- of 1% SDS, 1% Triton X-100, and 1% sodium deoxycholate in TBS
(10 mM Tris [pH 8.0], 150 mM NaCl, 1 mM MgCl2) and then dilutedgation at 15,000 g for 20 min and 100,000 g for 40 min at 48C.
Supernatants were passed through an immobilized GST-Sepharose. 10-fold to produce the membrane fraction.
The flowthrough was incubated with an affinity column containing
4 mg GST-PLCg1-SH2(C) immobilized on 1 ml Glutathione-Sepha- Acknowledgments
rose. Beads were then washed with 10 bed volumes of lysis buffer
containing 0.5 M NaCl, 10 bed volumes of lysis buffer, and eluted The authors thank Dr. M. Thomas for the anti-CD45 antiserum, D.
twice with 2 ml lysis buffer containing 1% SDS for 5 min at 958C. Chu for preparing LAK cells, JBW for generating the FLAG-PLCg1
The eluate was adjusted to 0.1% SDS. The diluted sample was cDNA constructs, and Drs. E. Brown, A. Shaw and M. Thomas for
incubated with 1 ml 50% slurry of an anti-pTyr MAb (PY20) immobi- critical reading of this manuscript. This work is funded in part by
lized on protein A-Sepharose (1 mg/ml) for 5 hr at 48C. Beads were grants from the NIH (R01 AI42787 and R01 CA71516). ACC is a Pew
washed with 20 ml of lysis buffer followed by 20 ml of buffer A (20 Scholar in the Biomedical Sciences and an Assistant Investigator
mM Tris-HCl [pH 8.0], 25 mM NaCl) and eluted with 2 ml of 100 mM of the Howard Hughes Medical Institute.
phenylphosphate (Sigma) in buffer A. Eluates were adjusted to 0.1%
SDS and dialyzed overnight against buffer A containing 0.1% SDS. Received May 21, 1998; revised June 15, 1998.
Three similar preparations were combined and the final sample was
concentrated using a Centriplus Concentrator (Amicon). Proteins References
were resolved on a 7% SDS-polyacrylamide gel and visualized with
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